Without insurance, Wegovy pens cost $349 a month through the manufacturer’s self-pay pharmacy. New patients pay $199 a month for the first two fills of the two lowest doses. The Wegovy pill costs $149 to $299 a month, depending on dose. These are the numbers published by NovoCare Pharmacy, and they have changed several times. Below you will find what each price covers, where the catches are, and what other routes exist if even $349 a month is more than you want to spend.
The price depends on the form (pen or pill), the dose, and whether you are a new patient. Novo Nordisk sells directly to self-paying patients, which is why the old sticker price of well over $1,000 a month no longer describes what most cash-paying patients actually pay.
| Form | Dose | Self-pay price per month |
|---|---|---|
| Pen | 0.25 mg and 0.5 mg, first two fills for new patients | $199 |
| Pen | 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg after the intro offer | $349 |
| Pen | 7.2 mg | $399 |
| Pill | 1.5 mg | $149 |
| Pill | 4 mg | $199 |
| Pill | 9 mg and 25 mg | $299 |
Source: NovoCare Pharmacy and a price roundup that reflects the July 2026 changes. One month means one box of four pens or one bottle of 30 tablets. Novo Nordisk reserves the right to change or end the program, so check the page before you order.
The manufacturer’s patient savings page lists the same $199 introductory price for the first two doses of 0.25 mg and 0.5 mg.
The pen starts at 0.25 mg and moves up on a schedule your prescriber sets. A typical first year, using the published prices, looks like this:
That is arithmetic on published prices, not a quote. If your dose reaches the 7.2 mg pen, the monthly figure is higher. If you stay on the pill, a first year at the lowest dose would be $1,788 at $149 a month, and more as you move up the doses.
One point people miss: weight-loss medication is generally meant to be used long term. Stopping often means weight comes back, so the yearly cost matters more than the first month’s price. Ask your prescriber what the plan is if you reach goal.
Search results for this topic disagree, and not because anyone is lying. Most of the confusion comes from four things.
When you compare quotes, compare the same thing: the same form, the same dose, the same number of months, all fees included.
Check coverage first. Many plans exclude weight-loss drugs, but some cover Wegovy, and others cover it for specific conditions.
If your commercial plan covers Wegovy, the manufacturer’s savings offer lets you pay as little as $25 a month, with savings capped at $100 a month. Government beneficiaries are excluded from that offer. Wegovy’s own cost and coverage page explains how it applies whether you use insurance or pay cash.
Call the member number on your card and ask three questions: is Wegovy on the formulary for weight management, is prior authorization required, and what BMI or comorbidity criteria apply. Our guide to weight-loss medication insurance coverage walks through those steps in more detail.
Medicare has a short-term route. The Medicare GLP-1 Bridge is a demonstration running from July 1, 2026 to December 31, 2027. It provides eligible Part D enrollees with access to certain GLP-1 drugs. Per CMS guidance for prescribers, eligibility rests on clinical criteria, including a BMI of 35 or higher, or a BMI of 30 or 27 with specific comorbidities, and the drug must be prescribed for weight reduction. The copay is $50.
It does not replace your normal plan. If the drug is prescribed for a condition Part D already covers, such as type 2 diabetes, that goes through your regular Part D plan. Our Medicare and weight-loss drugs article covers this in more depth.
If $349 a month for the pen is too much, you have a few options. Each has trade-offs.
Switch to the pill. At $149 to $299 a month, the pill is the lowest-priced way to get brand-name Wegovy. You would need to talk to a prescriber about whether it suits you, since the pill and pen are different products with different dosing.
Use the intro offer well. The two-month $199 offer is useful for testing how you tolerate the medication before committing to a longer plan.
Employer programs. Some employers offer GLP-1 programs outside the health plan. If your company is looking at one, we run an employer GLP-1 program from $160 a month.
Compounded semaglutide. This is the route that gets the lowest monthly price, and it is also the one that needs the most careful reading, so it gets its own section.
There is no FDA-approved generic of Wegovy. The FDA states that the semaglutide medicines are available only by prescription and that no approved generic versions exist. It also cautions that compounded products have not been shown to be as safe or effective, and may use different ingredients or salt forms.
Compounded medication is made by a pharmacy for an individual patient on a prescription. It is not reviewed by the FDA for safety, effectiveness or quality the way an approved drug is. That is a real difference, and you should hear it from any provider before you buy.
The FDA also pays attention to how companies market these products. In February 2026 it sent warning letters to telehealth companies, including one claiming the “same active ingredient” as Wegovy and Ozempic. The agency’s concern is that wording like that can imply approval that compounded drugs do not have. A trustworthy provider will not tell you a compounded product is Wegovy, and will not tell you it is FDA-approved.
If you are considering compounded semaglutide, ask:
Our compounded semaglutide safety article goes through these questions, and semaglutide myths clears up common misunderstandings.
We get asked the Wegovy price question every day, and our honest answer starts with a correction: Wegovy is cheaper for cash payers than it was a year ago, and the manufacturer’s own pharmacy is a legitimate option. If your priority is the brand-name, FDA-approved product, that is the place to look, and nobody should push you away from it.
Where we come in is for people who need a lower monthly cost, or who want a physician-led program built around more than a prescription. Our semaglutide starts at $119 a month and our tirzepatide at $185 a month. Our compounded injectable semaglutide starts at $167 a month. These are compounded medications, not Wegovy and not FDA-approved, and we say so up front.
Here is how our program works. You fill out a health questionnaire, a licensed physician reviews it, and if you are approved the medication is delivered to your door. There is no video call required. We include health coaching and support, and we pair weight loss with strength and lifestyle protocols, because losing weight while preserving lean muscle is what keeps metabolic health improving.
Our advice: decide on the product first, then compare price. Do not pick a cheaper option because a headline said it was the same as Wegovy. It is not, and a good provider will tell you that.
— Eric
Use this checklist before you pay anyone.
For our own pricing across telehealth plans, see our GLP-1 telehealth cost breakdown and our semaglutide cost article.
Wegovy and other GLP-1 medicines are prescription drugs, and they are not right for everyone. Talk to a physician before you start, especially if you have type 2 diabetes, a history of pancreatitis, gallbladder disease, kidney disease, or a personal or family history of thyroid cancer. Tell the prescriber if you are pregnant or planning to be. Your clinician can check your medication list and tell you which option fits your health, whatever the price.
If you take diabetes medicines, do not change doses on your own. Your prescriber needs to manage that.
If you want a lower monthly cost and ongoing support, you can see what is available on our semaglutide page or our tirzepatide page. Approved prescriptions ship to your door, with free shipping and no hidden membership fees. A licensed physician reviews your questionnaire and decides whether treatment is appropriate for you.
The pen costs $349 a month through NovoCare Pharmacy, with a $199 intro price for the first two fills of the 0.25 mg and 0.5 mg doses through December 31, 2026. The pill is $149 for 1.5 mg, $199 for 4 mg, and $299 for the 9 mg and 25 mg doses. Prices can change, so confirm on the NovoCare page.
No. The FDA says there are no approved generic versions of the semaglutide medicines. Compounded semaglutide is a separate product made by a pharmacy, and it is not FDA-approved.
No. The savings offer that brings the cost to as little as $25 a month is for people with commercial insurance that covers Wegovy, and it is capped at $100 in monthly savings. Without coverage, the self-pay prices above are the relevant ones.
Through the Medicare GLP-1 Bridge, eligible patients can pay a $50 copay between July 1, 2026 and December 31, 2027. You must meet BMI and clinical criteria and not be eligible for Part D coverage of the drug for another condition. Ask your prescriber and plan to confirm where you fall.
Not automatically. Compare the product, dose, fees and prescriber, not only the monthly figure. Brand-name Wegovy and compounded semaglutide are different products, so the right choice depends on your health, your budget and what you want from a provider.
